Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success

STAT News·October 15, 2026 at 7:58 PM

statnews.com

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.

Chat about this story

Quick actions

STAT News1 day ago

Last updated 1 day ago

17°

Isolated showers

High 17°

Low 5°

Sat

17°

5°

Sun

15°

2°

Mon

17°

5°

Tue

19°

12°

Wed

17°

10°

Last updated 1 day ago

8,908.43+0.78%